News
UCSF Study Finds a Better Way to Screen for Breast Cancer
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match people to the amount of screening they need. The results — which come from 46
Community Advisory Board Celebrates 20 Years of Collaboration and Impact
The Helen Diller Family Comprehensive Cancer Center recently celebrated the 20th anniversary of its Community Advisory Board (CAB). Held at UCSF Mission Bay, the celebration was attended by current and former CAB members, longstanding community partners, and leaders and staff from the HDFCCC Office
Thirdhand Smoke: This Hidden Danger Puts Kids and Adults at Risk
Most people know secondhand smoke is harmful — but thirdhand smoke? That’s the toxic residue tobacco leaves behind on surfaces like carpets, furniture, wall boards, and clothing, where it can linger for years. Neal Benowitz, MD UC San Francisco professor emeritus of medicine Researchers from UC San
International Breast Cancer Conference Features UCSF Experts
Breast cancer experts from UCSF Health will present trial results and clinical guidance at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 9–12, 2025. Combining clinical, translational and basic
UCSF Health Experts Spotlight Advances, Receive Recognition at National Hematology/Oncology Conference
Hematologists and oncologists from UCSF will share research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology – the American Society of Hematology’s (ASH) 67th Annual Meeting and Exposition. This year’s meeting will be held in Orlando, Dec. 6-9
Seven Research Projects Funded through Cancer Health Outcomes SPORE
Seven cancer research investigators have been awarded grants this fall through the UCSF Cancer Health Outcomes Specialized Program in Research Excellence (SPORE). This new $12 million SPORE supports three translational research projects that study the biological mechanisms and external factors
Improving Management and Treatment of Thyroid Cancer
Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid cancer (DTC) to provide clinicians, patients, and researchers with a comprehensive and objective set